Alignment Healthcare (NASDAQ:ALHC) Insider Sells $237,885.56 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 12,694 shares of the business’s stock in a transaction on Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $237,885.56. Following the transaction, the insider owned 349,639 shares in the company, valued at approximately $6,552,234.86. The trade was a 3.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Hyong Kim also recently made the following trade(s):

• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.57, for a total transaction of $902,729.03.
• On Wednesday, October 8th, Hyong Kim sold 33,655 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.29, for a total transaction of $581,894.95.

Alignment Healthcare Stock Up 2.7%

Alignment Healthcare stock opened at $19.75 on Friday. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The company’s 50-day moving average is $18.31 and its 200-day moving average is $16.27. The firm has a market capitalization of $3.95 billion, a PE ratio of -164.58 and a beta of 1.16. Alignment Healthcare, Inc. has a fifty-two week low of $11.01 and a fifty-two week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The business had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.Alignment Healthcare’s quarterly revenue was up 43.5% on a year-over-year basis. During the same quarter last year, the company posted ($0.14) earnings per share. Sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ALHC shares. JPMorgan Chase & Co. increased their price target on Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. UBS Group increased their price objective on shares of Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $22.00 price target on shares of Alignment Healthcare in a research note on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.35.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the business. Mirabella Financial Services LLP acquired a new stake in Alignment Healthcare in the 3rd quarter worth about $186,000. Hudson Bay Capital Management LP bought a new position in shares of Alignment Healthcare during the third quarter worth approximately $4,581,000. Allworth Financial LP raised its position in shares of Alignment Healthcare by 28.3% in the third quarter. Allworth Financial LP now owns 6,351 shares of the company’s stock valued at $111,000 after buying an additional 1,402 shares in the last quarter. CIBC Bancorp USA Inc. bought a new stake in shares of Alignment Healthcare in the third quarter valued at approximately $272,000. Finally, Maven Securities LTD bought a new stake in shares of Alignment Healthcare in the third quarter valued at approximately $872,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.